by OmegaQuant | Jan 17, 2019 | EPA & DHA, Heart Health, Omega-3 Index, Research
While many people are aware of omega-3s, many are not sure exactly what they do. Let’s start with what they are first. There are three main omega-3 fatty acids: eicosapentaenoic acid (EPA), docosapentaenoic acid (DHA) and alpha linolenic acid (ALA). Only ALA is...
by OmegaQuant | Jan 9, 2019 | Blood Pressure, Heart Health, Omega-3 Index, Omega-3s, Research
It is one of the most popular questions asked about omega-3s— do they lower cholesterol? The simple answer is no, they don’t lower cholesterol. But they do have an impact on other risk factors related to heart disease, such as triglycerides, blood pressure and the...
by OmegaQuant | Jan 2, 2019 | Brain Health, EPA & DHA, Heart Health, Omega-3 Index, Omega-3s, Research
2018 was a great year for omega-3s EPA and DHA with more positive news than bad for change. And it seems you liked our research highlights the most. Below are the most-read blog posts of 2018. Enjoy the recap! #7 – The Study that Could Turn the Tide for Omega-3s EPA...
by OmegaQuant | Dec 17, 2018 | Omega-3s
With the holidays approaching, it is natural to find yourself slipping away from your typical dietary routine. But if you’ve gone Keto, there are plenty of reasons to stick with it. One excellent reason is because the Keto diet has the potential to deliver an...
by OmegaQuant | Dec 12, 2018 | Omega-3 Index, Research
It’s that time of year again! Nope, not the holidays. For millions of Americans, it’s time to find a new health insurance plan or renew an existing one. But thankfully this blog is not about health insurance. This blog is about the Omega-3 Index test and how it is...
These statements have not been evaluated by the Food and Drug Administration. This test is not intended to diagnose, treat, cure, prevent or mitigate any disease. This site does not offer medical advice, and nothing contained herein is intended to establish a doctor/patient relationship. OmegaQuant, LLC is regulated under the Clinical Laboratory improvement Amendments of 1988 (CLIA) and is qualified to perform high complexity clinical testing. The performance characteristics of this test were determined by OmegaQuant, LLC. It has not been cleared or approved by the U.S. Food and Drug Administration.
